Associations between the annual number of meal payments related to sacubitril/valsartan and the annual number of Medicare claims and Medicare spending
| Variables | OR for proportion of sacubitril/valsartan prescriptions relative to all sacubitril/valsartan, ARB and ACEi prescriptions (95% CI), OR | P value | Percentage difference in the annual medicare claims per physician (95% CI), % | P value | Percentage difference in the annual medicare spending per physician (95% CI), % | P value |
| Meal payments related to sacubitril/valsartan | ||||||
| Same-year model | ||||||
| Receipt of meal payments related to sacubitril/valsartan in same year of prescription (yes or no) | 2.04 (1.98 to 2.10) | <0.001 | – | – | – | – |
| 10% increase in the annual number of meal payments in same year of prescription | – | – | 2.6 (2.5 to 2.7) | <0.001 | 7.3 (7.1 to 7.5) | <0.001 |
| One-year gap model | ||||||
| Receipt of meal payments related to sacubitril/valsartan 1 year prior to prescription (yes or no) | 1.97 (1.91 to 2.02) | <0.001 | – | – | – | – |
| 10% increase in the annual number of meal payments 1 year prior to prescription | – | – | 3.6 (3.5 to 3.7) | <0.001 | 9.6 (9.4 to 9.9) | <0.001 |
ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker.